Skip to content

SIR-Spheres

INSYTE with SurePlanTM LiverY90

insyte

Collaboration between Sirtex Medical and MIM Software Inc. advances innovation and increases precision of liver-directed oncology therapies for patients.


Inyte Logo

Insyte


SurePlan

care

MIM Software Inc. is the legal manufacturer of the SurePlan LiverY90 Software.
SurePlan is a trademark of MIM Software Inc.

 


Resources

Indications for Use: SIR-Spheres Y-90 resin microspheres are indicated for the treatment of unresectable metastatic liver tumors from primary colorectal cancer with adjuvant intrahepatic artery chemotherapy (IHAC) . of FUDR (Floxuridine). Consult the Instructions for Use for a complete listing of indications, contraindications, side effects, warnings, and precautions.
if (showPopover) { }